The role of mucosal barriers in human gut health
- PMID: 33890250
- DOI: 10.1007/s12272-021-01327-5
The role of mucosal barriers in human gut health
Abstract
The intestinal mucosa is continuously exposed to a large number of commensal or pathogenic microbiota and foreign food antigens. The intestinal epithelium forms a dynamic physicochemical barrier to maintain immune homeostasis. To efficiently absorb nutrients from food, the epithelium in the small intestine has thin, permeable layers spread over a vast surface area. Epithelial cells are renewed from the crypt toward the villi, accompanying epithelial cell death and shedding, to control bacterial colonization. Tight junction and adherens junction proteins provide epithelial cell-cell integrity. Microbial signals are recognized by epithelial cells via toll-like receptors. Environmental signals from short-chain fatty acids derived from commensal microbiota metabolites, aryl hydrocarbon receptors, and hypoxia-induced factors fortify gut barrier function. Here we summarize recent findings regarding various environmental factors for gut barrier function. Further, we discuss the role of gut barriers in the pathogenesis of human intestinal disease and the challenges of therapeutic strategies targeting gut barrier restoration.
Keywords: Barrier function; Epithelial cell; Gut; Inflammation; Inflammatory bowel disease.
References
-
- Aihara E, Engevik KA, Montrose MH (2017) Trefoil factor peptides and gastrointestinal function. Annu Rev Physiol 79:357–380. https://doi.org/10.1146/annurev-physiol-021115-105447 - DOI - PubMed
-
- Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA (2019) The intestinal epithelium: central coordinator of mucosal immunity: (Trends in Immunology 39, 677–696, 2018). Trends Immunol 40(2):174. https://doi.org/10.1016/j.it.2018.12.0082018.12.008 - DOI - PubMed
-
- Angus HCK, Butt AG, Schultz M, Kemp RA (2019) Intestinal organoids as a tool for inflammatory bowel disease research. Front Med (Lausanne) 6:334. https://doi.org/10.3389/fmed.2019.00334 - DOI
-
- Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD (2004) RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci USA 101(37):13596–13600. https://doi.org/10.1073/pnas.0404034101 - DOI - PubMed
-
- Atreya R, Bloom S, Scaldaferri F, Gerardi V, Admyre C, Karlsson A, Knittel T, Kowalski J, Lukas M, Lofberg R, Nancey S, Petryka R, Rydzewska G, Schnabel R, Seidler U, Neurath MF, Hawkey C (2016) Clinical effects of a topically applied toll-like receptor 9 agonist in active moderate-to-severe ulcerative colitis. J Crohns Colitis 10(11):1294–1302. https://doi.org/10.1093/ecco-jcc/jjw103 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources